PROPANC BIOPHARMA, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
PROPANC BIOPHARMA, INC. (PPCB) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$378.00 thousand for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2025-05-15
- PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$658.76K.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-12-31 was -$285.66K.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was -$785.67K.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$601.56K.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$2.05M.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$4.50M.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$1.43M.
- PROPANC BIOPHARMA, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$226.44K.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-03-31 | -$378.00K 10-Q · filed 2025-05-15 | |||||
| 2018-03-31 | -$658.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | -$944.42K derived: sum of 2 quarters · filed 2018-05-10 | -$1.73M 10-Q · filed 2018-05-10 | -$2.33M derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2017-12-31 | -$285.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-09 | -$1.07M 10-Q · filed 2018-02-09 | -$1.67M derived: sum of 3 quarters · filed 2018-02-09 | -$2.12M derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2017-09-30 | -$785.67K 10-Q · filed 2017-11-09 | -$1.39M derived: sum of 2 quarters · filed 2017-11-09 | -$1.83M derived: sum of 3 quarters · filed 2018-05-10 | -$2.15M derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2017-06-30 | -$601.56K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$1.05M derived: sum of 2 quarters · filed 2018-05-10 | -$1.37M derived: sum of 3 quarters · filed 2018-05-10 | -$2.05M 10-K · filed 2017-09-28 | ||
| 2017-03-31 | -$444.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | -$765.48K derived: sum of 2 quarters · filed 2018-05-10 | -$1.45M 10-Q · filed 2018-05-10 | -$3.75M derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2016-12-31 | -$321.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-09 | -$1.00M 10-Q · filed 2018-02-09 | -$3.30M derived: sum of 3 quarters · filed 2018-02-09 | -$4.02M derived: sum of 4 quarters · filed 2018-02-09 | ||
| 2016-09-30 | -$683.60K 10-Q · filed 2017-11-09 | -$2.98M derived: sum of 2 quarters · filed 2017-11-09 | -$3.70M derived: sum of 3 quarters · filed 2017-11-09 | -$4.78M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | -$2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$3.01M derived: sum of 2 quarters · filed 2017-09-28 | -$4.10M derived: sum of 3 quarters · filed 2017-09-28 | -$4.50M 10-K · filed 2017-09-28 | -$4.50M 10-K · filed 2016-09-28 | |
| 2016-03-31 | -$716.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | -$1.80M derived: sum of 2 quarters · filed 2017-05-08 | -$2.21M 10-Q · filed 2017-05-08 | -$2.93M derived: sum of 4 quarters · filed 2017-05-08 | ||
| 2015-12-31 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-14 | -$1.49M 10-Q · filed 2017-02-14 | -$2.22M derived: sum of 3 quarters · filed 2017-02-14 | -$2.64M derived: sum of 4 quarters · filed 2017-02-14 | ||
| 2015-09-30 | -$405.71K 10-Q · filed 2016-11-10 | -$627.24K 10-Q · filed 2015-11-16 | -$1.13M derived: sum of 2 quarters · filed 2016-11-10 | -$1.56M derived: sum of 3 quarters · filed 2016-11-10 | -$1.73M derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | -$728.94K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | -$1.15M derived: sum of 2 quarters · filed 2016-09-28 | -$1.33M derived: sum of 3 quarters · filed 2016-09-28 | -$1.43M 10-K · filed 2016-09-28 | ||
| 2015-03-31 | -$425.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-16 | -$597.73K derived: sum of 2 quarters · filed 2016-05-16 | -$697.54K 10-Q · filed 2016-05-16 | -$786.32K derived: sum of 4 quarters · filed 2016-05-16 | ||
| 2014-12-31 | -$172.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-16 | -$272.00K 10-Q · filed 2016-02-16 | -$360.77K derived: sum of 3 quarters · filed 2016-02-16 | -$396.62K derived: sum of 4 quarters · filed 2016-02-16 | ||
| 2014-09-30 | -$99.81K 10-Q · filed 2015-11-16 | -$99.81K 10-Q · filed 2014-11-19 | -$188.59K derived: sum of 2 quarters · filed 2015-11-16 | -$224.43K derived: sum of 3 quarters · filed 2015-11-16 | -$251.07K derived: sum of 4 quarters · filed 2015-11-16 | |
| 2014-06-30 | -$88.78K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-30 | -$124.62K derived: sum of 2 quarters · filed 2015-09-30 | -$151.26K derived: sum of 3 quarters · filed 2015-09-30 | -$226.44K 10-K · filed 2015-09-30 | ||
| 2014-03-31 | -$35.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | -$62.48K derived: sum of 2 quarters · filed 2015-05-15 | -$137.67K 10-Q · filed 2015-05-15 | |||
| 2013-12-31 | -$26.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | -$101.82K 10-Q · filed 2015-02-17 | ||||
| 2013-09-30 | -$75.18K 10-Q · filed 2014-11-19 | |||||
| 2013-06-30 | -$128.65K 10-K · filed 2014-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |